Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study

Clinical trial NCT05013957 · COMPLETED

Trial details

NCT number: NCT05013957
Sponsor: University Hospital, Basel, Switzerland
Status: COMPLETED
Study type: OBSERVATIONAL

Neuroendocrine Tumors

Start date: 2022-01-01
Primary completion: 2024-12-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.